Riskpilot← Back to searchSign inGet full accessØYEKLINIKKEN I NARVIK AS
ASActiveOrg 883197372Administrasjonsveien 1B, 8514 NarvikMedical specialists activities · NACE 8622Est. 20010 employees
Revenue 2024
NOK 0
EBITDA margin
—
+98% vs 2023
Equity ratio
-358.1%
Financial strength
Net profit 2024
NOK -12K
+98% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -3K | +98% |
| Net profit | NOK -12K | +98% |
| Total assets | NOK 743K | -3% |
| Equity | NOK -2,7M | +0% |
| Employees | 0 | — |
Legal name
ØYEKLINIKKEN I NARVIK AS
Org number
883197372
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
7. april 2001
Share capital
NOK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Å drive medisinsk og kirurgisk virksomhet for behandling av øyesykdommer, samt annen virksomhet som naturlig faller sammen med dette. Selskapet kan også delta i annen virksomhet med økonomisk formål.
Address
Administrasjonsveien 1B, 8514 Narvik
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 456 | 0 | 0 | 0 | 0 |
| Staff expenses | −92 | −0 | −0 | −0 | −0 |
| EBITDA | −1 891 | −631 | −68 | −140 | −3 |
| Depreciation & amort. | 2 458 | −466 | −350 | −450 | −0 |
| EBIT | 567 | −1 097 | −418 | −590 | −3 |
| Net financials | −407 | −61 | −61 | −65 | −9 |
| Profit before tax | 160 | −1 158 | −480 | −654 | −12 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 160 | −1 158 | −480 | −654 | −12 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 566 | 1 613 | 1 267 | 762 | 743 |
| Equity | −356 | −1 514 | −1 994 | −2 648 | −2 660 |
| Long-term debt | 1 913 | 1 473 | 996 | 577 | 549 |
| Short-term debt | 2 009 | 1 654 | 2 265 | 2 834 | 2 853 |
| Total debt | 3 922 | 3 127 | 3 261 | 3 410 | 3 402 |
EBITDA margin
-257500.0%
This company
15.8%
Market median
-1629847% vs market
20202024
Equity ratio
-358.1%
This company
38.2%
Market median
-1037% vs market
20202024
Return on equity
-1154700.0%
This company
18.4%
Market median
-6275643% vs market
20202024
Net profit margin
-1154700.0%
This company
8.1%
Market median
-14255656% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
1.28×
This company
0.62×
Market median
-106% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2020 | |
| Former (1) | ||
| Board of Directors | 2020 – 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ØYEKLINIKKEN I NARVIK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Christine Bussoli | Board of Directors | 0 companies |
| Jens Kratholm | Chairman | 0 companies |